Literature DB >> 22640759

New systems of care for substance use disorders: treatment, finance, and technology under health care reform.

David R Pating1, Michael M Miller, Eric Goplerud, Judith Martin, Douglas M Ziedonis.   

Abstract

This article outlined ways in which persons with addiction are currently underserved by our current health care system. However, with the coming broad scale reforms to our health care system, the access to and availability of high-quality care for substance use disorders will increase. Addiction treatments will continue to be offered through traditional substance abuse care systems, but these will be more integrated with primary care, and less separated as treatment facilities leverage opportunities to blend services, financing mechanisms, and health information systems under federally driven incentive programs. To further these reforms, vigilance will be needed by consumers, clinicians, and policy makers to assure that the unmet treatment needs of individuals with addiction are addressed. Embedded in this article are essential recommendations to facilitate the improvement of care for substance use disorders under health care reform. Ultimately, as addiction care acquires more of the “look and feel” of mainstream medicine, it is important to be mindful of preexisting trends in health care delivery overall that are reflected in recent health reform legislation. Within the world of addiction care, clinicians must move beyond their self-imposed “stigmatization” and sequestration of specialty addiction treatment. The problem for addiction care, as it becomes more “mainstream,” is to not comfortably feel that general slogans like “Treatment Works,” as promoted by Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Treatment during its annual Recovery Month celebrations, will meet the expectations of stakeholders outside the specialty addiction treatment community. Rather, the problem is to show exactly how addiction treatment works, and to what extent it works-there have to be metrics showing changes in symptom level or functional outcome, changes in health care utilization, improvements in workplace attendance and productivity, or other measures. At minimum, clinicians will be required to demonstrate that their new systems of care and future clinical activity are in conformance with overall standards of “best practice” in health care.

Entities:  

Mesh:

Year:  2012        PMID: 22640759     DOI: 10.1016/j.psc.2012.03.004

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  35 in total

1.  Expected Impact of Health Care Reform on the Organization and Service Delivery of Publicly Funded Addiction Health Services.

Authors:  Erick G Guerrero; Lesley Harris; Howard Padwa; William A Vega; Lawrence Palinkas
Journal:  Adm Policy Ment Health       Date:  2017-07

2.  States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Jennifer R Havens; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2015-10-09       Impact factor: 4.492

3.  An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Authors:  Gerald Cochran; Adam J Gordon; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Winfred Frazier; Carroline Lobo; Chung-Chou H Chang; Ping Zheng; Julie M Donohue
Journal:  Med Care       Date:  2017-03       Impact factor: 2.983

4.  Effect of the Exclusion of Behavioral Health from Health Information Technology (HIT) Legislation on the Future of Integrated Health Care.

Authors:  Deborah Cohen
Journal:  J Behav Health Serv Res       Date:  2015-10       Impact factor: 1.505

5.  Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.

Authors:  Hannah K Knudsen; Jamie L Studts
Journal:  J Behav Health Serv Res       Date:  2019-01       Impact factor: 1.505

6.  Costs of screening and brief intervention for illicit drug use in primary care settings.

Authors:  Gary Zarkin; Jeremy Bray; Jesse Hinde; Richard Saitz
Journal:  J Stud Alcohol Drugs       Date:  2015-03       Impact factor: 2.582

7.  A pilot replication of QUIT, a randomized controlled trial of a brief intervention for reducing risky drug use, among Latino primary care patients.

Authors:  Lillian Gelberg; Ronald M Andersen; Melvin W Rico; Mani Vahidi; Guillermina Natera Rey; Steve Shoptaw; Barbara D Leake; Martin Serota; Kyle Singleton; Sebastian E Baumeister
Journal:  Drug Alcohol Depend       Date:  2017-06-13       Impact factor: 4.492

8.  Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.

Authors:  Udi E Ghitza; Betty Tai
Journal:  J Health Care Poor Underserved       Date:  2014-02

9.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

Review 10.  A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults.

Authors:  Rachel D Maree; Zachary A Marcum; Ester Saghafi; Debra K Weiner; Jordan F Karp
Journal:  Am J Geriatr Psychiatry       Date:  2016-06-07       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.